FDA approves Biofinity toric multifocal contact lenses
Click Here to Manage Email Alerts
The FDA granted approval for the CooperVision Biofinity toric multifocal contact lenses, which combines the optical designs of the existing Biofinity toric and multifocal contacts.
“Biofinity toric multifocal extends the reliable performance of our Biofinity toric lenses to presbyopic patients,” Michele Andrews, OD, senior director of professional and academic affairs of North America at CooperVision, said in a press release from the company. “U.S. eye care professionals will soon have an easy-to-fit, familiar lens design they can count on to keep current toric wearers satisfied in contact lenses for longer and provide new astigmatic wearers an alternative to reading glasses. It’s a win-win for practitioners and their patients.”
The design of the new multifocal contact lens provides options for fitting a center D or center N lens. Each lens has spherical, central and peripheral zones with a progressive intermediate zone.
The company plans to make the lenses available in the U.S. later this year and to provide further details of lens parameters in the coming months.